Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Finasteride (5mg) Tablet
Therapeutic Category
ENDOCRINOLOGY and Hormonal range, Urology, Endocrinology
Dosage Form
Tablet
Packaging Type
Blister
Packaging
10*10
Price
₹219/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Finaslide 5 Tablet contains Finasteride 5mg, a 5-alpha reductase inhibitor that works by blocking the conversion of testosterone into dihydrotestosterone (DHT). DHT is a key factor in the enlargement of the prostate gland, and by reducing its levels, Fincurl 5 Tablet helps reduce the size of the prostate, easing symptoms of BPH such as frequent urination, difficulty urinating, and urgency. It also reduces the risk of acute urinary retention and the need for prostate surgery.
The effect of Finaslide 5 Tablet on BPH is typically seen after 3 to 6 months of consistent use. It is important for patients to follow the prescribed dosage and not to discontinue the medication without consulting their doctor, as doing so may reverse the benefits.
Common side effects include sexual dysfunction (decreased libido, erectile dysfunction), dizziness, and fatigue. Rare effects may include breast tenderness or enlargement.
Fincurl 5 Tablet is used to treat benign prostatic hyperplasia (BPH) and reduce the risk of acute urinary retention and prostate surgery in men.
Consult your doctor before use if you have liver disease or plan to father a child, as finasteride may affect sperm quality.
Store at room temperature, away from moisture and heat. Keep out of the reach of children.
Composition : Bromfenac (0.09% w/v) + Moxifloxacin (0.5% w/v)
Composition : Bromfenac (0.9mg) Eye Drops
Composition : Carboxymethylcellulose (3mg/ml) + Glycerin (10mg/ml) + n-acetylcarnosine (10mg/ml)
Composition : Dexamethasone (0.1% w/v) + Tobramycin (0.3% w/v)
Composition : Fluconazole (0.3% w/v)
Composition : Gatifloxacin (0.3% w/v)
Composition : Ketorolac (0.4% w/v) + Olopatadine (0.1% w/v)
Composition : Ketorolac (0.5% w/v)
Composition : Ketorolac (5% w/v) + Moxifloxacin (0.5% w/v)
Composition : Loteprednol etabonate (0.5% w/v)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Finasteride 5mg Tablet is primarily used for benign prostatic hyperplasia (BPH), making it a high-demand urology and chronic-care prescription product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma pharma franchise market.
Medical distributors and wholesalers can benefit from steady demand in urology clinics and long-term therapy prescriptions for prostate enlargement management. It is commonly prescribed by urologists for improving urinary flow and managing BPH symptoms.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for Finasteride 5mg Tablet with monopoly rights, quality urology formulations, competitive pricing, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from long-term prescription cycles, stable urology clinic demand, and repeat sales due to chronic therapy requirements when partnering with Cafoli Lifecare.
Medical distributors, stockists, wholesalers, and pharma professionals interested in this urology formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, pricing, and distribution support services.